Compare CACC & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CACC | NOVT |
|---|---|---|
| Founded | 1972 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.0B |
| IPO Year | 1996 | 1999 |
| Metric | CACC | NOVT |
|---|---|---|
| Price | $545.96 | $145.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $596.67 | $194.50 |
| AVG Volume (30 Days) | 104.7K | ★ 366.7K |
| Earning Date | 10-29-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.00 | N/A |
| EPS | ★ 25.04 | 0.82 |
| Revenue | ★ $2,317,200,000.00 | $521,290,000.00 |
| Revenue This Year | $91.15 | $15.57 |
| Revenue Next Year | $6.09 | $15.87 |
| P/E Ratio | ★ $21.89 | $176.40 |
| Revenue Growth | 7.16 | ★ 35.49 |
| 52 Week Low | $401.90 | $98.27 |
| 52 Week High | $668.86 | $176.38 |
| Indicator | CACC | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 53.74 |
| Support Level | $529.10 | $141.72 |
| Resistance Level | $572.47 | $151.41 |
| Average True Range (ATR) | 15.49 | 5.40 |
| MACD | 1.94 | 0.51 |
| Stochastic Oscillator | 67.07 | 67.94 |
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.